| Ordinary Shares |
253,898 |
$355,457 |
$1.40 |
06 Aug 2024 |
By New Leaf Ventures III, L.P. |
|
|
| Ordinary Shares |
91,122 |
$127,571 |
$1.40 |
06 Aug 2024 |
By New Leaf Biopharma Opportunities II, L.P. |
|
|
| Warrants (right to buy) |
182,453 |
|
|
06 Aug 2024 |
By New Leaf Ventures III, L.P. |
Ordinary Shares |
|
| Warrants (right to buy) |
65,481 |
|
|
06 Aug 2024 |
By New Leaf Biopharma Opportunities II, L.P. |
Ordinary Shares |
|
| Subscription Rights (right to buy) |
0 |
|
|
06 Aug 2024 |
By New Leaf Biopharma Opportunities II, L.P. |
Units |
|
| Subscription Rights (right to buy) |
0 |
|
|
06 Aug 2024 |
By New Leaf Ventures III, L.P. |
Units |
|
| 6.500% Exchangeable Senior Subordinated Note due 2025 |
$0 |
|
|
13 Jan 2025 |
By New Leaf Biopharma Opportunities II, L.P. |
Ordinary Shares |
|
| 6.500% Exchangeable Senior Subordinated Note due 2025 |
$0 |
|
|
13 Jan 2025 |
By New Leaf Ventures III, L.P. |
Ordinary Shares |
|